HEMOGLOBIN VARIANT ANALYSIS (HB-HPLC)

The Hemoglobin Variant Analysis (Hb-HPLC) Test is an advanced laboratory investigation used to identify, quantify, and characterize normal and abnormal hemoglobin fractions in the blood. The test utilizes High-Performance Liquid Chromatography (HPLC) technology, a highly accurate and reliable method for diagnosing hemoglobin disorders and inherited blood diseases.

Hemoglobin is the oxygen-carrying protein found in red blood cells. Normally, adults have predominantly Hemoglobin A (HbA), with smaller amounts of Hemoglobin A2 (HbA2) and Fetal Hemoglobin (HbF). Genetic mutations can lead to abnormal hemoglobin variants, resulting in conditions known as hemoglobinopathies.

Hb-HPLC is widely regarded as one of the preferred screening and diagnostic methods for identifying disorders such as beta-thalassemia, sickle cell disease, Hemoglobin E disease, Hemoglobin D disease, and other hemoglobin variants. The test provides precise quantification of hemoglobin fractions, helping physicians accurately diagnose and classify inherited blood disorders.

Benefits of the Test

• Detects abnormal hemoglobin variants
• Screens for thalassemia carriers
• Helps diagnose sickle cell disease
• Quantifies HbA, HbA2, and HbF levels
• Supports genetic counseling programs
• Provides highly accurate and reliable results

Why Doctors Recommend This Test

Doctors may recommend Hemoglobin Variant Analysis (Hb-HPLC) for:

• Suspected thalassemia
• Suspected sickle cell disease
• Unexplained anemia
• Family history of hemoglobin disorders
• Premarital screening
• Prenatal screening programs
• Carrier detection for inherited blood disorders
• Evaluation of abnormal blood counts

The test helps identify inherited hemoglobin abnormalities and supports appropriate treatment planning and family counseling.

Preparation Before Test

The test requires:

• Peripheral venous blood sample

Preparation generally includes:

• No fasting is required
• Inform your doctor about recent blood transfusions
• Provide relevant family history if available
• Follow laboratory instructions for sample collection

Recent blood transfusions may affect test interpretation and should be disclosed before testing.

Normal Reporting Time

Results are generally available within 2 to 5 working days, depending on laboratory workflow and testing methodology.

Who Should Take This Test?

• Individuals with unexplained anemia
• Patients with suspected thalassemia
• Individuals with suspected sickle cell disease
• Couples planning pregnancy
• Persons with a family history of hemoglobin disorders
• Individuals undergoing carrier screening

Hb-HPLC is a valuable diagnostic and screening tool for inherited blood disorders and hemoglobinopathies.

Clinical Significance

The test may help diagnose:

• Beta Thalassemia Trait
• Beta Thalassemia Major
• Sickle Cell Disease
• Sickle Cell Trait
• Hemoglobin E Disease
• Hemoglobin D Disease
• Hereditary Persistence of Fetal Hemoglobin (HPFH)
• Other Hemoglobin Variants

Elevated HbA2 levels may suggest beta-thalassemia trait, while abnormal hemoglobin peaks may indicate specific hemoglobinopathies.

Important Note

Hb-HPLC results should be interpreted along with complete blood count (CBC), red cell indices, iron studies, clinical history, and family history. In certain cases, molecular genetic testing may be recommended for confirmation and detailed characterization.